|
|
(State or Other Jurisdiction of Incorporation)
|
(I.R.S. Employer Identification No.)
|
|
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
|
|
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
|
|
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
|
|
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
|
Title of each class
|
Trading
Symbol(s)
|
Name of each exchange on which registered
|
||
Exhibit
Number |
|
Description
|
104
|
Cover Page Interactive Data File (embedded within the Inline XBRL document)
|
BERRY GLOBAL GROUP, INC.
(Registrant)
|
|||
Dated: November 16, 2023
|
By:
|
/s/ Jason K. Greene |
|
Name: |
Jason K. Greene |
||
Title: |
Executive Vice President, Chief Legal Officer and Secretary | ||
|
News Release
|
|
|
•
|
GAAP: Net sales of $3.1 billion; Operating income of $301 million; Earnings per share (EPS) of $1.55
|
•
|
Non-GAAP: Operating EBITDA of $547 million; Adjusted EPS of $2.28
|
•
|
Returned $216 million to shareholders ($185 million via share repurchases and $31 million in dividends)
|
•
|
GAAP: Net sales of $12.7 billion; Operating income of $1.1 billion; EPS of $4.95
|
•
|
Non-GAAP: Operating EBITDA of $2.05 billion; Adjusted EPS of $7.42
|
•
|
Cash flow from operations of $1.6 billion; Free cash flow of $926 million
|
•
|
Returned $728 million to shareholders ($601 million via share repurchases and $127 million in dividends)
|
•
|
Adjusted EPS range of $7.35 - $7.85 per share
|
•
|
Cash flow from operations range of $1.35 - $1.45 billion; Free cash flow range of $800 - $900 million
|
•
|
Announced a 10% increase to the quarterly dividend to $0.275 per share
|
•
|
Committed to debt reduction along with returning capital to shareholders through share repurchases and dividends
|
Kevin Kwilinski, Berry’s new CEO said, “I am pleased to report we exceeded our adjusted earnings per share outlook and significantly beat our free
cash flow guidance by over $100 million. Our 3% volume decline in the quarter improved sequentially and was better than expected, as soft market demand was mitigated by market share gains supported by recent capital investments. During the
year, our organization took actions and demonstrated agility to offset challenging and volatile global market dynamics characterized by ongoing inflation, soft consumer demand and customer destocking. Our proven business model has generated
eleven consecutive years of adjusted earnings per share growth and strong, consistent generation of free cash flow. We are dedicated to delivering long-term value for our shareholders, as evidenced by our $728 million of capital returned in
fiscal 2023, through both our share repurchases of $601 million, or approximately 8% of shares outstanding, along with quarterly dividend payments.
In line with our commitment to drive long-term shareholder value, we expect to use our cash in fiscal 2024 to reduce our debt, repurchase shares
opportunistically, and pay our recently increased dividend. Looking ahead, we are optimistic about our future and expect a more normal operating environment in fiscal 2024. We believe that, both the easing of inflationary pressures on
consumers and the increase of promotional activity by our customers will lead to demand improvement as the year progresses.”
|
September Quarter
|
Fiscal Year
|
|||||||||||||||
GAAP results
|
2023
|
2022
|
2023
|
2022
|
||||||||||||
Net sales
|
$
|
3,087
|
$
|
3,421
|
$
|
12,664
|
$
|
14,495
|
||||||||
Operating income
|
301
|
336
|
1,079
|
1,242
|
||||||||||||
EPS (diluted)
|
1.55
|
1.85
|
4.95
|
5.77
|
September Quarter
|
Reported
|
Comparable
|
Fiscal Year
|
Reported
|
Comparable
|
|||||||||||||||||||||||||||
Adjusted non-GAAP results
|
2023
|
2022
|
%
|
%
|
2023
|
2022
|
%
|
%
|
||||||||||||||||||||||||
Net sales
|
$
|
3,087
|
$
|
3,421
|
(10
|
%)
|
(12
|
%)
|
$
|
12,664
|
$
|
14,495
|
(13
|
%)
|
(12
|
%)
|
||||||||||||||||
Operating EBITDA
|
547
|
539
|
1
|
%
|
flat
|
2,053
|
2,101
|
(2
|
%)
|
flat
|
||||||||||||||||||||||
Adjusted EPS (diluted)
|
2.28
|
2.19
|
4
|
%
|
1
|
%
|
7.42
|
7.40
|
flat
|
1
|
%
|
(1)
|
Adjusted non-GAAP results exclude items not considered to be ongoing operations. In addition, comparable
change % excludes the impacts of foreign currency, acquisitions, and recent divestitures. Further details related to non-GAAP measures and reconciliations can be found under our “Non-GAAP Financial Measures and Estimates” section or
in reconciliation tables in this release. In millions of USD, except per share data
|
•
|
Adjusted earnings per share range of $7.35 - $7.85
|
•
|
Cash flow from operations range of $1.35-$1.45 billion; free cash flow range of $800-900 million
|
•
|
Committed to debt reduction along with returning capital to shareholders through share repurchases and dividends
|
Quarterly Period Ended
|
Fiscal Year Ended
|
|||||||||||||||
September 30, 2023
|
October 1, 2022
|
September 30, 2023
|
October 1, 2022
|
|||||||||||||
Net sales
|
$
|
3,087
|
$
|
3,421
|
$
|
12,664
|
$
|
14,495
|
||||||||
Costs and expenses:
|
||||||||||||||||
Cost of goods sold
|
2,481
|
2,834
|
10,354
|
12,123
|
||||||||||||
Selling, general and administrative
|
215
|
185
|
886
|
850
|
||||||||||||
Amortization of intangibles
|
62
|
61
|
243
|
257
|
||||||||||||
Restructuring and transaction activities
|
28
|
5
|
102
|
23
|
||||||||||||
Operating income
|
301
|
336
|
1,079
|
1,242
|
||||||||||||
Other expense
|
18
|
9
|
31
|
22
|
||||||||||||
Interest expense, net
|
78
|
74
|
306
|
286
|
||||||||||||
Income before income taxes
|
205
|
253
|
742
|
934
|
||||||||||||
Income tax expense
|
19
|
20
|
133
|
168
|
||||||||||||
Net income
|
$
|
186
|
$
|
233
|
$
|
609
|
$
|
766
|
||||||||
Basic net income per share
|
$
|
1.59
|
$
|
1.87
|
$
|
5.07
|
$
|
5.87
|
||||||||
Diluted net income per share
|
1.55
|
1.85
|
4.95
|
5.77
|
||||||||||||
Outstanding weighted average shares (in millions)
|
||||||||||||||||
Basic
|
117.3
|
124.7
|
120.1
|
130.6
|
||||||||||||
Diluted
|
120.2
|
126.0
|
123.0
|
132.8
|
||||||||||||
(in millions of USD)
|
September 30, 2023
|
October 1, 2022
|
||||||
Cash and cash equivalents
|
$
|
1,203
|
$
|
1,410
|
||||
Accounts receivable
|
1,568
|
1,777
|
||||||
Inventories
|
1,557
|
1,802
|
||||||
Other current assets
|
205
|
175
|
||||||
Property, plant, and equipment
|
4,576
|
4,342
|
||||||
Goodwill, intangible assets, and other long-term assets
|
7,478
|
7,450
|
||||||
Total assets
|
$
|
16,587
|
$
|
16,956
|
||||
Current liabilities, excluding current debt
|
2,703
|
2,831
|
||||||
Current and long-term debt
|
8,980
|
9,255
|
||||||
Other long-term liabilities
|
1,688
|
1,674
|
||||||
Stockholders’ equity
|
3,216
|
3,196
|
||||||
Total liabilities and stockholders' equity
|
$
|
16,587
|
$
|
16,956
|
Fiscal Year Ended
|
||||||||
(in millions of USD)
|
September 30, 2023
|
October 1, 2022
|
||||||
Cash flows from operating activities:
|
||||||||
Net income
|
$
|
609
|
$
|
766
|
||||
Depreciation
|
575
|
562
|
||||||
Amortization of intangibles
|
243
|
257
|
||||||
Non-cash interest, net
|
(61
|
)
|
6
|
|||||
Settlement of derivatives
|
36
|
201
|
||||||
Deferred income tax
|
(117
|
)
|
(48
|
)
|
||||
Share-based compensation expense
|
42
|
39
|
||||||
Other non-cash operating activities, net
|
22
|
(22
|
)
|
|||||
Changes in working capital
|
266
|
(198
|
)
|
|||||
Net cash from operating activities
|
1,615
|
1,563
|
||||||
Cash flows from investing activities:
|
||||||||
Additions to property, plant, and equipment, net
|
(689
|
)
|
(687
|
)
|
||||
Settlement of net investment hedges
|
-
|
76
|
||||||
Divestiture (acquisition) of businesses and other
|
(87
|
)
|
128
|
|||||
Net cash from investing activities
|
(776
|
)
|
(483
|
)
|
||||
Cash flows from financing activities:
|
||||||||
Repayments on long-term borrowings
|
(869
|
)
|
(22
|
)
|
||||
Proceeds from long-term borrowings
|
496
|
-
|
||||||
Repurchase of common stock
|
(601
|
)
|
(709
|
)
|
||||
Proceeds from issuance of common stock
|
36
|
27
|
||||||
Dividends paid
|
(127
|
)
|
-
|
|||||
Other, net
|
(6
|
)
|
-
|
|||||
Net cash from financing activities
|
(1,071
|
)
|
(704
|
)
|
||||
Effect of currency translation on cash
|
25
|
(57
|
)
|
|||||
Net change in cash and cash equivalents
|
(207
|
)
|
319
|
|||||
Cash and cash equivalents at beginning of period
|
1,410
|
1,091
|
||||||
Cash and cash equivalents at end of period
|
$
|
1,203
|
$
|
1,410
|
||||
Non-U.S. GAAP Free Cash Flow:
|
||||||||
Cash flow from operating activities
|
$
|
1,615
|
$
|
1,563
|
||||
Additions to property, plant, and equipment (net)
|
(689
|
)
|
(687
|
)
|
||||
Non-U.S. GAAP Free Cash Flow
|
$
|
926
|
$
|
876
|
Quarterly Period Ended September 30, 2023
|
||||||||||||||||||||
(in millions of USD)
|
Consumer Packaging - International
|
Consumer Packaging- North America
|
Health, Hygiene & Specialties
|
Engineered Materials
|
Total
|
|||||||||||||||
Net sales
|
$
|
1,000
|
$
|
786
|
$
|
630
|
$
|
671
|
$
|
3,087
|
||||||||||
Operating income
|
$
|
84
|
$
|
94
|
$
|
36
|
$
|
87
|
$
|
301
|
||||||||||
Depreciation and amortization
|
80
|
58
|
45
|
29
|
212
|
|||||||||||||||
Restructuring and transaction activities
|
18
|
7
|
2
|
1
|
28
|
|||||||||||||||
Other non-cash charges (1)
|
2
|
2
|
1
|
1
|
6
|
|||||||||||||||
Operating EBITDA
|
$
|
184
|
$
|
161
|
$
|
84
|
$
|
118
|
$
|
547
|
||||||||||
Quarterly Period Ended October 1, 2022
|
||||||||||||||||||||
Reported net sales
|
$
|
1,003
|
$
|
888
|
$
|
738
|
$
|
792
|
$
|
3,421
|
||||||||||
Foreign currency and divestitures
|
56
|
13
|
25
|
9
|
103
|
|||||||||||||||
Comparable net sales (2)
|
$
|
1,059
|
$
|
901
|
$
|
763
|
$
|
801
|
$
|
3,524
|
||||||||||
Operating income
|
$
|
98
|
$
|
103
|
$
|
44
|
$
|
91
|
$
|
336
|
||||||||||
Depreciation and amortization
|
75
|
53
|
43
|
28
|
199
|
|||||||||||||||
Restructuring and transaction activities
|
—
|
2
|
3
|
—
|
5
|
|||||||||||||||
Other non-cash charges (1)
|
(1
|
)
|
—
|
—
|
—
|
(1
|
)
|
|||||||||||||
Foreign currency and divestitures
|
7
|
4
|
(5
|
)
|
1
|
7
|
||||||||||||||
Comparable operating EBITDA (2)
|
$
|
179
|
$
|
162
|
$
|
85
|
$
|
120
|
$
|
546
|
(1)
|
Other non-cash charges are primarily stock compensation expense
|
(2)
|
The prior year comparable basis change excludes the impacts of foreign currency, acquisitions, and divestitures. Further details related to non-GAAP
measures and reconciliations can be found under our “Non-GAAP Financial Measures and Estimates” section or in reconciliation tables in this release.
|
Fiscal Year Ended September 30, 2023
|
||||||||||||||||||||
(in millions of USD)
|
Consumer Packaging - International
|
Consumer Packaging- North America
|
Health, Hygiene & Specialties
|
Engineered Materials
|
Total
|
|||||||||||||||
Net sales
|
$
|
4,031
|
$
|
3,122
|
$
|
2,627
|
$
|
2,884
|
$
|
12,664
|
||||||||||
Operating income
|
$
|
273
|
$
|
346
|
$
|
127
|
$
|
333
|
$
|
1,079
|
||||||||||
Depreciation and amortization
|
310
|
217
|
177
|
114
|
818
|
|||||||||||||||
Restructuring and transaction activities
|
50
|
23
|
22
|
7
|
102
|
|||||||||||||||
Other non-cash charges (1)
|
25
|
12
|
8
|
9
|
54
|
|||||||||||||||
Operating EBITDA
|
$
|
658
|
$
|
598
|
$
|
334
|
$
|
463
|
$
|
2,053
|
||||||||||
Fiscal Year Ended October 1, 2022
|
||||||||||||||||||||
Reported net sales
|
$
|
4,293
|
$
|
3,548
|
$
|
3,166
|
$
|
3,488
|
$
|
14,495
|
||||||||||
Foreign currency and divestitures
|
(167
|
)
|
26
|
7
|
(31
|
)
|
(165
|
)
|
||||||||||||
Comparable net sales (2)
|
$
|
4,126
|
$
|
3,574
|
$
|
3,173
|
$
|
3,457
|
$
|
14,330
|
||||||||||
Operating income
|
$
|
346
|
$
|
338
|
$
|
230
|
$
|
328
|
$
|
1,242
|
||||||||||
Depreciation and amortization
|
317
|
214
|
176
|
112
|
819
|
|||||||||||||||
Restructuring and transaction activities
|
10
|
5
|
6
|
2
|
23
|
|||||||||||||||
Other non-cash charges (1)
|
(5
|
)
|
8
|
8
|
6
|
17
|
||||||||||||||
Foreign currency and divestitures
|
(31
|
)
|
9
|
(13
|
)
|
(3
|
)
|
(38
|
)
|
|||||||||||
Comparable operating EBITDA (2)
|
$
|
638
|
$
|
574
|
$
|
407
|
$
|
445
|
$
|
2,064
|
(1)
|
Other non-cash charges are primarily stock compensation expense
|
(2)
|
The prior year comparable basis change excludes the impacts of foreign currency, acquisitions, and divestitures. Further details related to non-GAAP
measures and reconciliations can be found under our “Non-GAAP Financial Measures and Estimates” section or in reconciliation tables in this release.
|
Quarterly Period Ended
|
Fiscal Year Ended
|
|||||||||||||||
September 30, 2023
|
October 1, 2022
|
September 30, 2023
|
October 1, 2022
|
|||||||||||||
Net income
|
$
|
186
|
$
|
233
|
$
|
609
|
$
|
766
|
||||||||
Add: other expense
|
18
|
9
|
31
|
22
|
||||||||||||
Add: interest expense
|
78
|
74
|
306
|
286
|
||||||||||||
Add: income tax expense
|
19
|
20
|
133
|
168
|
||||||||||||
Operating income
|
$
|
301
|
$
|
336
|
$
|
1,079
|
$
|
1,242
|
||||||||
Add: restructuring and transaction activities
|
28
|
5
|
102
|
23
|
||||||||||||
Add: other non-cash charges (1)
|
6
|
(1
|
)
|
54
|
17
|
|||||||||||
Adjusted operating income (4)
|
$
|
335
|
$
|
340
|
$
|
1,235
|
$
|
1,282
|
||||||||
Add: depreciation
|
150
|
138
|
575
|
562
|
||||||||||||
Add: amortization of intangibles
|
62
|
61
|
243
|
257
|
||||||||||||
Operating EBITDA (4)
|
$
|
547
|
$
|
539
|
$
|
2,053
|
$
|
2,101
|
||||||||
Net income per diluted share
|
$
|
1.55
|
$
|
1.85
|
$
|
4.95
|
$
|
5.77
|
||||||||
Other expense, net
|
0.15
|
0.07
|
0.25
|
0.17
|
||||||||||||
Restructuring and transaction activities
|
0.23
|
0.04
|
0.83
|
0.17
|
||||||||||||
Amortization of intangibles from acquisitions (2)
|
0.52
|
0.48
|
1.98
|
1.94
|
||||||||||||
Non-comparable tax items (3)
|
—
|
(0.14
|
)
|
—
|
(0.13
|
)
|
||||||||||
Income tax impact on items above
|
(0.17
|
)
|
(0.14
|
)
|
(0.59
|
)
|
(0.52
|
)
|
||||||||
Foreign currency, acquisitions, and divestitures
|
—
|
0.06
|
—
|
(0.06
|
)
|
|||||||||||
Adjusted net income per diluted share (4)
|
$
|
2.28
|
$
|
2.25
|
$
|
7.42
|
$
|
7.34
|
Estimated Fiscal 2024
|
||||
Cash flow from operating activities
|
$
|
1,350-1,450
|
||
Net additions to property, plant, and equipment
|
(550
|
)
|
||
Free cash flow (4)
|
$
|
800-900
|
(1)
|
Other non-cash charges are primarily stock compensation expense
|
(2)
|
Amortization of intangibles from acquisition are added back to better align our calculation of adjusted EPS with peers.
|
(3)
|
During the 2022 fiscal year, the Company obtained certain tax benefits of $18 million deemed as non-comparable.
|
(4)
|
Supplemental financial measures that are not required by, or presented in accordance with, accounting principles generally
accepted in the United States (“GAAP”). These non-GAAP financial measures should not be considered as alternatives to operating or net income or cash flows from operating activities, in each case determined in accordance with GAAP.
Organic sales growth and comparable basis measures exclude the impact of currency translation effects and acquisitions. These non-GAAP financial measures may be calculated differently by other companies, including other companies in our
industry, limiting their usefulness as comparative measures. Berry’s management believes that adjusted net income and other non-GAAP financial measures are useful to our investors because they allow for a better period-over-period
comparison of operating results by removing the impact of items that, in management’s view, do not reflect our core operating performance.
|
|
We define “free cash flow” as cash flow from operating activities, less net additions to property, plant, and equipment. We believe free cash flow is
useful to an investor in evaluating our liquidity because free cash flow and similar measures are widely used by investors, securities analysts, and other interested parties in our industry to measure a company’s liquidity. We also believe
free cash flow is useful to an investor in evaluating our liquidity as it can assist in assessing a company’s ability to fund its growth through its generation of cash.
|
|
We also use Adjusted operating EBITDA, Adjusted EPS and comparable basis measures, among other measures, to evaluate management performance and in
determining performance-based compensation. Operating EBITDA is a measure widely used by investors, securities analysts, and other interested parties in our industry to measure a company’s performance. We also believe EBITDA and Adjusted
operating income are useful to an investor in evaluating our performance without regard to revenue and expense recognition, which can vary depending upon accounting methods.
(BERY-F)
|